Predictive value of baseline CD66e/CEA serum levels on efficacy of bevacizumab-based treatment in advanced colorectal cancer.
Gerald W. Prager
Honoraria - Amgen; Amgen
Kira H. Bramswig
No relevant relationships to disclose
Christoph Zielinski
Consultant or Advisory Role - Merck Serono; Roche
Honoraria - Roche